List of Willis Towers Watson Neuron Customers
London, EC3M 7DQ,
United Kingdom
Since 2010, our global team of researchers has been studying Willis Towers Watson Neuron customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Willis Towers Watson Neuron for Trading Platform from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Willis Towers Watson Neuron for Trading Platform include: Markel, a United States based Insurance organisation with 22000 employees and revenues of $16.62 billion, Liberty Specialty Markets, a United Kingdom based Insurance organisation with 1900 employees and revenues of $4.79 billion and many others.
Contact us if you need a completed and verified list of companies using Willis Towers Watson Neuron, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Willis Towers Watson Neuron customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Liberty Specialty Markets | Insurance | 1900 | $4.8B | United Kingdom | Willis Towers Watson | Willis Towers Watson Neuron | Trading Platform | 2025 | n/a |
In 2025 Liberty Specialty Markets implemented Willis Towers Watson Neuron, a Trading Platform, as an early adopter to accelerate digital trading in the London Market. The deployment is positioned through a strategic partnership with Willis Towers Watson to modernise placement workflows for complex specialty risks and to deepen broker connectivity across follow-line business.
Willis Towers Watson Neuron was configured to provide real-time connectivity between brokers and insurers, instrumenting trading and placement workflows with market-wide connectivity and algorithmic pricing capabilities described by the vendor. Functional modules emphasized include real-time trade orchestration, placement workflow automation, and portfolio-level underwriting configuration to enable tailored underwriting solutions and faster execution of follow-line business.
Operational coverage centers on underwriting and distribution workflows, connecting LSM underwriting teams with broker channels to enable a faster, more flexible way to trade risks and to scale placement activity. The platform is described as linking London Market trading activity to global risk placement, improving the efficiency of broker access to underwriting expertise and standardising data-driven decisioning across the trading value chain.
Governance and rollout are framed as an early adopter collaboration with WTW, with LSM focusing on process simplification to make the risk placement process faster and frictionless for follow business and to strengthen broker relationships. Reported outcomes include simplified and accelerated trading, enhanced efficiency across the insurance value chain, and improved speed, scale, and effectiveness of placing follow-line business using Willis Towers Watson Neuron.
|
 |
Markel | Insurance | 22000 | $16.6B | United States | Willis Towers Watson | Willis Towers Watson Neuron | Trading Platform | 2022 | n/a |
In 2022, Markel International served as a pilot participant in Willis Towers Watson Neuron, a Trading Platform, to test end-to-end digital trading and market connectivity in the London specialty market. The pilot engagement positioned Willis Towers Watson Neuron to exercise connectivity across broker and insurer workflows and to validate digital trading flows against established market procedures.
The implementation activity focused on market connectivity and digital facilities capabilities within Willis Towers Watson Neuron, exercising electronic facility handling, submission routing, and standardized message exchange patterns consistent with Trading Platform functional expectations. Configuration work emphasized connectivity modules and processing pipelines to support bidirectional communication between market participants and insurer underwriting interfaces, aligning platform configuration with market workflow requirements.
Integrations validated during the 2022 pilot included broker system and insurer system connectivity at scale, demonstrating Willis Towers Watson Neuron's ability to mediate trade flows between external broker systems and Markel underwriting systems. The pilot was scoped to the London specialty market and run in 2022 as a targeted systems and process validation, and public reporting indicates the pilot validated Neuron's ability to connect broker and insurer systems at scale.
|
Buyer Intent: Companies Evaluating Willis Towers Watson Neuron
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||